Eli Lilly And Co vs Schwab US Dividend Equity ETF — how do they compare? Eli Lilly And Co trades at $1,214.24 (market cap $1.08T), while Schwab US Dividend Equity ETF trades at $34.27. The key difference: Eli Lilly And Co pays a 0.57% dividend while Schwab US Dividend Equity ETF pays none. Which is the better fit depends on your goals.
| LLY | SCHD | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.24K | $34.27 |
52-Week Low | $639.43 | $26.44 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →